Foresite Capital Management Ii, LLC 10x Genomics, Inc. Transaction History
Foresite Capital Management Ii, LLC
- $29.2 Million
- Q3 2023
A detailed history of Foresite Capital Management Ii, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Foresite Capital Management Ii, LLC holds 708,528 shares of TXG stock, worth $5.79 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
708,528
Previous 708,528
-0.0%
Holding current value
$5.79 Million
Previous $39.6 Million
26.13%
% of portfolio
100.0%
Previous 100.0%
Shares
9 transactions
Others Institutions Holding TXG
# of Institutions
304Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$105 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$90.8 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$58 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$52.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$43.9 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $777M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...